Crossref
26-A-16687-ACC MINIMAL BLOOD PRESSURE EFFECTS OF INTRANASAL ETRIPAMIL IN TRIALS FOR PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA
JACC · 2026-04 · 87 (13) · A62
DOI: 10.1016/j.jacc.2026.02.155 ↗Kurz gefasst
Fachartikel in der Zeitschrift JACC, 2026-04. Verfasst von James Edmund Ip und 8 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Ip, J. E., Noseworthy, P., Rafii, F., Piccini, J. P., Singh, N., Stambler, B. S., Shardonofsky, S., Bharucha, D. B., & Camm, A. J. (2026). 26-A-16687-ACC MINIMAL BLOOD PRESSURE EFFECTS OF INTRANASAL ETRIPAMIL IN TRIALS FOR PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA. JACC, 87(13), A62. https://doi.org/10.1016/j.jacc.2026.02.155
Vancouver
Ip JE, Noseworthy P, Rafii F, Piccini JP, Singh N, Stambler BS, et al. 26-A-16687-ACC MINIMAL BLOOD PRESSURE EFFECTS OF INTRANASAL ETRIPAMIL IN TRIALS FOR PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA. JACC. 2026;87(13):A62. doi:10.1016/j.jacc.2026.02.155
BibTeX
@article{Ip2026,
author = {Ip, James Edmund and Noseworthy, Peter and Rafii, Farhad and Piccini, Jonathan P. and Singh, Narendra and Stambler, Bruce Sheldon and Shardonofsky, Silvia and Bharucha, David B. and Camm, A. John},
title = {26-A-16687-ACC MINIMAL BLOOD PRESSURE EFFECTS OF INTRANASAL ETRIPAMIL IN TRIALS FOR PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA},
journal = {JACC},
year = {2026},
volume = {87},
number = {13},
pages = {A62},
doi = {10.1016/j.jacc.2026.02.155}
}
EUVIMED